Tuesday 14th April, 2015
7:00am to 5:00pm
Bpi Europe is more than just a conference, it’s a time to pause and reflect on the real challenges facing the production, quality and analysis of biologics, an opportunity to challenge conventional thinking and work as an community to prepare for the next wave of products, processes and technologies shaping the future of your industry, your company and ultimately, your career.
What's new for 2015?
New pricing structure: £999 Flash rate until 31 Dec 2014
£499 for academics
50% SME Discounts
TOP Speakers include:
Dr Anthony Mire-Sluis, Vice President, North America, Singapore, Contract and Product Quality, Amgen, USA
Dr Rahul Singhvi, Chief Operating Officer, Takeda Vaccines, USA
Dr Niklas Engler, Head, Technical Development, Biologics Europe, Roche, Switzerland
Dr Craig Smith, VP, Business Development and R&D, BioScience Division, Thermo Fisher, USA
Dr Gunter Jagschies, Strategic Customer Relations Lead, GE Healthcare, Sweden
Dr Jens Vogel, Global Head, CMC Strategy and TRA Biopharm, Boehringer Ingelheim, Germany
Dr Roman Necina, Vice President Process Science & Technical Operations, Baxter Innovations GmbH, Austria
10 New Sessions focusing on:
FDA Breakthrough Strategy
Quality Management Agreements
Continued Process Verification
PD for Novel Therapies
6 New workshops:
Extractables and Leachables
PAT and In-Process Testing
Outsourcing, Tech Transfer and CMO-Client Relationships
BPI Knowledge Exchange - Join the discussion tables with the experts who will be evaluating: Process Development for Novel therapies and Quality by design, shared experiences.
BPI Live Labs - Hear direct practical application in the lab, Product Showcases from our exhibitors onsite
Booking : http://atnd.it/18250-1
Price : see website for more prices - £999
Speakers : Dr Craig Smith, VP, BD and R&D, BioScience Division, Thermo Fisher, USA, Dr Gunter Jagschies Strategic Customer Relations Lead GE Healthcare, SwedenDr Jens Vogel, Global Head, CMC Strategy and TRA Biopharm, Boehringer Ingelheim, Germany, Dr Rahul Singhvi, Chief Operating Officer, Takeda Vaccines, USA.
Sign in to add slides, notes or videos to this session